Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARISOPRODOL vs CARTEOLOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARISOPRODOL vs CARTEOLOL: Safety Overview

Metric CARISOPRODOL CARTEOLOL
Total FAERS Reports 2,660 318
Deaths Reported 1,332 30
Death Rate 50.1% 9.4%
Hospitalizations 432 93
Average Patient Age 48.1 yrs 67.5 yrs
% Female Patients 63.6% 56.6%
FDA Approval Date Approved Prior to Jan 1, 1982 Dec 28, 1988
Manufacturer ScieGen Pharmaceuticals, Inc. Sandoz Inc
Route ORAL OPHTHALMIC
Marketing Status Prescription Discontinued